BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23377871)

  • 1. Transthoracic bioimpedance and brain natriuretic peptide assessment for prognostic stratification of outpatients with chronic systolic heart failure.
    Malfatto G; Corticelli A; Villani A; Giglio A; Della Rosa F; Branzi G; Facchini M; Parati G
    Clin Cardiol; 2013 Feb; 36(2):103-9. PubMed ID: 23377871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic stratification of patients with chronic systolic heart failure using biomarkers and Doppler echocardiography.
    Ghio S; Alessandrino G; Albertini R; Klersy C; Girardi B; Maggi G; Pazzano AS; Raineri C; Scelsi L; Visconti LO
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):470-5. PubMed ID: 24983266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status.
    Pimenta J; Paulo C; Mascarenhas J; Gomes A; Azevedo A; Rocha-Gonçalves F; Bettencourt P
    Int J Cardiol; 2010 Nov; 145(2):209-214. PubMed ID: 19729213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between thoracic fluid content and natriuretic peptide type B in patients with systolic heart failure.
    Balak W; Sinkiewicz W; Gilewski W; Karasek D; Błazejewski J; Dudziak J
    Kardiol Pol; 2009 Nov; 67(11):1220-5. PubMed ID: 20024849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of matrix metalloproteinase 9 and brain natriuretic peptide as clinical biomarkers in chronic heart failure.
    Vorovich EE; Chuai S; Li M; Averna J; Marwin V; Wolfe D; Reilly MP; Cappola TP
    Am Heart J; 2008 Jun; 155(6):992-7. PubMed ID: 18513509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
    Feola M; Aspromonte N; Canali C; Ceci V; Giovinazzo P; Milani L; Quarta G; Ricci R; Scardovi AB; Uslenghi E; Valle R
    Am J Cardiol; 2005 Sep; 96(5):705-9. PubMed ID: 16125500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthoracic impedance accurately estimates pulmonary wedge pressure in patients with decompensated chronic heart failure.
    Malfatto G; Blengino S; Perego GB; Branzi G; Villani A; Facchini M; Parati G
    Congest Heart Fail; 2012; 18(1):25-31. PubMed ID: 22277174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
    Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex assessment of patients with decompensated heart failure: The clinical value of impedance cardiography and N-terminal pro-brain natriuretic peptide.
    Galas A; Krzesiński P; Gielerak G; Piechota W; Uziębło-Życzkowska B; Stańczyk A; Piotrowicz K; Banak M
    Heart Lung; 2019; 48(4):294-301. PubMed ID: 30391076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
    Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
    J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes.
    Karavidas A; Lazaros G; Matsakas E; Farmakis D; Parissis J; Paraskevaidis IA; Michailidis C; Avramidis D; Zacharoulis A; Arapi S; Kaoukis A; Zacharoulis A
    Heart Vessels; 2008 May; 23(3):181-6. PubMed ID: 18484161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthoracic bioimpedance and brain natriuretic peptide levels accurately indicate additional diastolic dysfunction in patients with chronic advanced systolic heart failure.
    Malfatto G; Branzi G; Giglio A; Villani A; Facchini C; Ciambellotti F; Facchini M; Parati G
    Eur J Heart Fail; 2010 Sep; 12(9):928-35. PubMed ID: 20562427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of B-type natriuretic peptide for assessment of left ventricular function in patients with chronic kidney disease.
    Soleimani A; Nasiri O; Nikoueinejad H; Mianehsaz E; Yousefzade M; Foroozanfard F; Tabatabaizadeh M; Moraveji SA; Rajali M
    Iran J Kidney Dis; 2011 Jul; 5(4):242-7. PubMed ID: 21725181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of proBNP1-108 testing for the risk stratification of patients with systolic heart failure.
    Gruson D; Lepoutre T; Ahn SA; Rousseau MF
    Peptides; 2013 Dec; 50():125-8. PubMed ID: 24140405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study.
    Dahou A; Clavel MA; Capoulade R; O'Connor K; Ribeiro HB; Côté N; Le Ven F; Rodés-Cabau J; Dumesnil JG; Mathieu P; Pibarot P
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):939-947. PubMed ID: 28917673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of the isovolumic relaxation time in the emergency diagnosis of new-onset congestive heart failure with preserved left ventricular systolic function in the setting of B-type natriuretic peptide levels in the mid-range.
    Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Ambrosi P; Luccioni R
    Int J Cardiol; 2008 Mar; 124(3):400-3. PubMed ID: 17395301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients.
    Simioniuc A; Carluccio E; Ghio S; Rossi A; Biagioli P; Reboldi G; Galeotti GG; Lu F; Zara C; Whalley G; Temporelli PL; Dini FL;
    Int J Cardiol; 2016 Dec; 224():416-423. PubMed ID: 27690339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic dysfunction and abnormal exercise ventilation predict adverse outcome in elderly patients with chronic systolic heart failure.
    Malfatto G; Branzi G; Giglio A; Ciambellotti F; Villani A; Parati G; Facchini M
    Eur J Prev Cardiol; 2012 Jun; 19(3):396-403. PubMed ID: 21450576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.